Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study

The titer of live attenuated viral vaccines, such as MMR vaccines, varies between batches and over the shelf-life of a batch, with the highest titer expected at batch release. As higher titers may theoretically lead to increased reactogenicity, we compared the safety profile of an upper-range releas...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343620/
https://www.ncbi.nlm.nih.gov/pubmed/30118386
http://dx.doi.org/10.1080/21645515.2018.1502527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343620/
https://www.ncbi.nlm.nih.gov/pubmed/30118386
http://dx.doi.org/10.1080/21645515.2018.1502527

Ejemplares similares